Cervical Cancer Brachytherapy With Interstitial Needles in 3 Fractions
Aim To determine the feasibility and safety of 3 fractions of high dose rate (HDR) brachytherapy with interstitial needles for cervical cancer in the outpatient setting

Primary objective To determine the clinical outcome (2-yr local control rate, loco-regional control rate, progression free survival and overall survival)

Secondary objective To determine the long-term toxicities of this regimen based on CTCAE v5
- EligibilityCriteria: Inclusion Criteria:  21 years old and above Histologically proven squamous cell carcinoma, adenocarcinoma, adenosquamous or poorly differentiated cervical cancer Clinically or radiologically stage IB - IVA cervical cancer based on TNM 8th Edition ECOG performance status 0, 1, or 2 To complete external beam radiotherapy and brachytherapy in NUH Written, voluntary informed consent Patients must be accessible for follow up and management in NUH  Exclusion Criteria:  Post operative cervical cancer cases Pregnant or breastfeeding women - HealthyVolunteers: No - Gender: Female - GenderBased: Yes - GenderDescription: As cervical cancer patients are females, we will only be recruiting female patients. - MinimumAge: 21 Years - StdAgeList: Adult, Older Adult